Published online 28 February 2005 doi:10.1084/jem.20041679
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 5, 805-816
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients
Paolo A. Muraro1,
Daniel C. Douek4,
Amy Packer1,
Katherine Chung1,
Francisco J. Guenaga4,
Riccardo Cassiani-Ingoni1,
Catherine Campbell2,
Sarfraz Memon5,
James W. Nagle3,
Frances T. Hakim5,
Ronald E. Gress5,
Henry F. McFarland1,
Richard K. Burt6, and
Roland Martin1
1 Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke
2 Information Technology Program, National Institute of Neurological Disorders and Stroke
3 DNA Sequencing Core Facility, National Institute of Neurological Disorders and Stroke
4 Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases
5 Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
6 Division of Immunotherapy, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60208
CORRESPONDENCE Paolo Muraro: murarop{at}ninds.nih.gov OR Roland Martin: martinr{at}ninds.nih.gov
Clinical trials have indicated that autologous hematopoietic stem cell transplantation (HSCT) can persistently suppress inflammatory disease activity in a subset of patients with severe multiple sclerosis (MS), but the mechanism has remained unclear. To understand whether the beneficial effects on the course of disease are mediated by lympho-depletive effects alone or are sustained by a regeneration of the immune repertoire, we examined the long-term immune reconstitution in patients with MS who received HSCT. After numeric recovery of leukocytes, at 2-yr follow-up there was on average a doubling of the frequency of naive CD4+ T cells at the expense of memory T cells. Phenotypic and T cell receptor excision circle (TREC) analysis confirmed a recent thymic origin of the expanded naive T cell subset. Analysis of the T cell receptor repertoire showed the reconstitution of an overall broader clonal diversity and an extensive renewal of clonal specificities compared with pretherapy. These data are the first to demonstrate that long-term suppression of inflammatory activity in MS patients who received HSCT does not depend on persisting lymphopenia and is associated with profound qualitative immunological changes that demonstrate a de novo regeneration of the T cell compartment.
Abbreviations used: AUC, area under the curve; CNS, central nervous system; EDSS, expanded disability status scale; HSCT, hematopoietic stem cell transplantation; MRI, magnetic resonance imaging; MS, multiple sclerosis; RTE, recent thymic emigrant; TBI, total body irradiation; TREC, T cell receptor excision circle.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
Out with the old, in with the new
- Heather L. Van Epps
J. Exp. Med. 2005 201: 663-664.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Kimiskidis, V., Sakellari, I., Tsimourtou, V., Kapina, V., Papagiannopoulos, S., Kazis, D., Vlaikidis, N., Anagnostopoulos, A., Fassas, A.
(2008). Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome. Mult Scler
14: 278-283
[Abstract]
-
Nash, R. A., McSweeney, P. A., Crofford, L. J., Abidi, M., Chen, C.-S., Godwin, J. D., Gooley, T. A., Holmberg, L., Henstorf, G., LeMaistre, C. F., Mayes, M. D., McDonagh, K. T., McLaughlin, B., Molitor, J. A., Nelson, J. L., Shulman, H., Storb, R., Viganego, F., Wener, M. H., Seibold, J. R., Sullivan, K. M., Furst, D. E.
(2007). High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood
110: 1388-1396
[Abstract]
[Full Text]
-
Portaccio, E., Amato, M.P., Siracusa, G., Pagliai, F., Sorbi, S., Guidi, S., Bosi, A., Saccardi, R.
(2007). Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases. Mult Scler
13: 676-678
[Abstract]
-
Martin, R.
(2007). Is haematopoietic stem cell transplantation a treatment option for severe MS or not?. Brain
130: 1181-1182
[Full Text]
-
Hauri-Hohl, M. M., Keller, M. P., Gill, J., Hafen, K., Pachlatko, E., Boulay, T., Peter, A., Hollander, G. A., Krenger, W.
(2007). Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation. Blood
109: 4080-4088
[Abstract]
[Full Text]
-
Voltarelli, J. C., Couri, C. E. B., Stracieri, A. B. P. L., Oliveira, M. C., Moraes, D. A., Pieroni, F., Coutinho, M., Malmegrim, K. C. R., Foss-Freitas, M. C., Simoes, B. P., Foss, M. C., Squiers, E., Burt, R. K.
(2007). Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus. JAMA
297: 1568-1576
[Abstract]
[Full Text]
-
Daikeler, T., Kotter, I., Bocelli Tyndall, C., Apperley, J., Attarbaschi, A., Guardiola, P., Gratwohl, A., Jantunen, E., Marmont, A., Porretto, F., Musso, M., Maurer, B., Rinaldi, N., Saccardi, R., Tyndall, A., for the EBMT Autoimmune Diseases Working Party,
(2007). Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature. Ann Rheum Dis
66: 202-207
[Abstract]
[Full Text]
-
Saccardi, R, Kozak, T, Bocelli-Tyndall, C, Fassas, A, Kazis, A, Havrdova, E, Carreras, E, Saiz, A, Lowenberg, B, te Boekhorst, P A., Gualandi, F, Openshaw, H, Longo, G, Pagliai, F, Massacesi, L, Deconink, E, Ouyang, J, Nagore, F J., Besalduch, J, Lisukov, I A, Bonini, A, Merelli, E, Slavin, S, Gratwohl, A, Passweg, J, Tyndall, A, Steck, A J, Andolina, M, Capobianco, M, Martin, J L., Lugaresi, A, Meucci, G, Saez, R A, Clark, R E, Fernandez, M N, Fouillard, L, Herstenstein, B, Koza, V, Cocco, E, Baurmann, H, Mancardi, G L, Autoimmune Diseases Working Party of EBMT,
(2006). Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler
12: 814-823
[Abstract]
-
Openshaw, H, Atkins, H L, Chen, J T, de Bittencourt, P R., Griffith, L M, Kerr, D A, Khoury, S A, Muraro, P A, Nash, R A, Saccardi, R
(2006). Multiple sclerosis conference synopsis and discussion: cellular therapy for treatment of autoimmune diseases (October 2005). Mult Scler
12: 824-825
[Abstract]
-
von Boehmer, H
(2006). Can studies of tolerance ever lead to therapy?. Ann Rheum Dis
65: iii41-iii43
[Abstract]
[Full Text]
-
Vezys, V., Masopust, D., Kemball, C. C., Barber, D. L., O'Mara, L. A., Larsen, C. P., Pearson, T. C., Ahmed, R., Lukacher, A. E.
(2006). Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med.
203: 2263-2269
[Abstract]
[Full Text]
-
van Laar, J. M., Tyndall, A.
(2006). Adult stem cells in the treatment of autoimmune diseases. Rheumatology (Oxford)
45: 1187-1193
[Abstract]
[Full Text]
-
de Kleer, I., Vastert, B., Klein, M., Teklenburg, G., Arkesteijn, G., Yung, G. P., Albani, S., Kuis, W., Wulffraat, N., Prakken, B.
(2006). Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood
107: 1696-1702
[Abstract]
[Full Text]
-
Marmont, A M, Gualandi, F, van Lint, M T, Guastoni, C, Bacigalupo, A
(2006). Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation. Lupus
15: 44-46
[Abstract]
-
Herrmann, M. M., Gaertner, S., Stadelmann, C., van den Brandt, J., Boscke, R., Budach, W., Reichardt, H. M., Weissert, R.
(2005). Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood
106: 1875-1883
[Abstract]
[Full Text]
-
Burt, R. K., Cohen, B., Rose, J., Petersen, F., Oyama, Y., Stefoski, D., Katsamakis, G., Carrier, E., Kozak, T., Muraro, P. A., Martin, R., Hintzen, R., Slavin, S., Karussis, D., Haggiag, S., Voltarelli, J. C., Ellison, G. W., Jovanovic, B., Popat, U., McGuirk, J., Statkute, L., Verda, L., Haas, J., Arnold, R.
(2005). Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. Arch Neurol
62: 860-864
[Full Text]